Sensars Neuroprosthetics Sàrl
High-selective nerve stimulators treating neuropathic pain
Sensars is a medtech start-up developing implantable neuroprosthetics for diabetic neuropathy complications such as diabetic foot ulcers, amputation and falls prevention and neuropathic pain treatment. Our flagship system, SENSY, restores natural foot sensation in patients with diabetes, sensory loss, or prosthetic limbs using neuromodulation and AI-driven gait analysis. By restoring sensation, SENSY prevents ulcers, amputations, falls, and chronic pain, improving patient survival and independence. Backed by FDA Breakthrough Device Designation, strong IP, and peer-reviewed clinical data, Sensars addresses a massive unmet need in diabetic foot care.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
12.06.2024
Sensars secures EUR 1.1 million in funding to advance revolutionary neuromodulation technology (venturelab.swiss)
11.06.2024
Sensars secures investment and two grants worth EUR 1.1 million (startupticker.ch)
28.10.2022
MassChallenge Switzerland 2022 Winners in the spotlight (startupticker.ch)
10.10.2022
Twelve startups compete for the MassChallenge Switzerland award prize (startupticker.ch)
09.05.2022
TOP 100 Satellite Event: 5 TOP 100 Swiss Startups pitch to Credit Suisse investors (TOP 100)
Last Tweets
20.01.2024
1.1M eur round of grants + convertible loan
No Jobs
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Sensars Neuroprosthetics Sàrl
High-selective nerve stimulators treating neuropathic pain
Website:
www.sensars.com
Headquarter:
Lausanne
Foundation Date:
June 2014
Technology:
- Medtech
Sectors:
- Micro technologies
- Medical devices
- Medtech
Support received
